Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States

References

• Hayes MJ, Brown MS. Legalization of medical marijuana and incidence of opioid mortality. JAMA Intern Med. 2014;174(10):1673–1674.
   PubMed Web of Science ®Google Scholar
• Smart R, Pacula RL. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019;45(6):644–663.
   PubMed Web of Science ®Google Scholar
• Khan SP, Pickens TA, Berlau DJ. Perspectives on cannabis as a substitute for opioid analgesics. Pain Manag. 2019;9(2):191–203.
   PubMed Web of Science ®Google Scholar
• Liang D, Bao Y, Wallace M, Grant I, Shi Y. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014. Addiction. 2018;113(11):2060–2070.
   PubMed Web of Science ®Google Scholar
• Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Intern Med. 2018;178(5):673–679.
   PubMed Web of Science ®Google Scholar
• Bradford AC, Bradford WD, Abraham A, Adams GB. Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Intern Med. 2018;178(5):667–672.
   PubMed Web of Science ®Google Scholar
• Livingston MD, Barnett TE, Delcher C, Wagenaar AC. Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015. Am J Public Health. 2017;107(11):1827–1829.
   PubMed Web of Science ®Google Scholar
• Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Intern Med. 2014;174(10):1668–1673.
   PubMed Web of Science ®Google Scholar
• Shi Y. Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Drug Alcohol Depend. 2017;173:144–150.
   PubMed Web of Science ®Google Scholar
• Chan NW, Burkhardt J, Flyr M. The effects of recreational marijuana legalization and dispensing on opioid mortality. Econ Inq. 2020;58(2):589–606.
   Web of Science ®Google Scholar
• Stockings E, Campbell G, Hall WD, et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 2018;159(10):1932–1954.
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. 2017. Available at: https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state. Accessed May 17, 2021.
   Google Scholar
• Nugent SM, Morasco BJ, O'Neil ME, et al. The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review. Ann Intern Med. 2017;167(5):319–331.
   PubMed Web of Science ®Google Scholar
• Eurich DT, Hanlon JG, Boisvenue JJ, Meng H, Dyck JRB. A description of the medical cannabis use in Ontario, Canada. Cannabis Cannabinoid Res. 2019;4(2):131–135.
   Google Scholar
• Corroon JM Jr, Mischley LK, Sexton M. Cannabis as a substitute for prescription drugs – a cross-sectional study. J Pain Res. 2017;10:989–998.
   PubMed Web of Science ®Google Scholar
• Lake S, Walsh Z, Kerr T, et al. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: a longitudinal analysis. PLoS Med. 2019;16(11):e1002967.
   PubMed Web of Science ®Google Scholar
• Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients. Int J Drug Policy. 2017;42:30–35.
   PubMed Web of Science ®Google Scholar
• Vigil JM, Stith SS, Adams IM, Reeve AP. Associations between medical cannabis and prescription opioid use in chronic pain patients: a preliminary cohort study. PLoS One. 2017;12(11):e0187795.
   PubMed Web of Science ®Google Scholar
• Gorfinkel LR, Stohl M, Greenstein E, Aharonovich E, Olfson M, Hasin D. Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis. Addiction. 2021;116(5):1113–1121.
   PubMed Web of Science ®Google Scholar
• Becker WC, Li Y, Caniglia EC, et al. Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: a target trial emulation study. AIDS Care. 2021;34:1–9.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Sabioni P, Trigo JM, et al. Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis. Neuropsychopharmacology. 2017;42(9):1752–1765.
   PubMed Web of Science ®Google Scholar
• Shover CL, Davis CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proc Natl Acad Sci USA. 2019;116(26):12624–12626.
   PubMed Web of Science ®Google Scholar
• Hall W, Lynskey M. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction. 2016;111(10):1764–1773.
   PubMed Web of Science ®Google Scholar
• Chihuri S, Li G. State marijuana laws and opioid overdose mortality. Injury Ep. 2019;6:1–12.
   PubMedGoogle Scholar
• Wendelboe AM, Mathew R, Chongsuwat T, et al. Is there less opioid abuse in states where marijuana has been decriminalized, either for medicinal or recreational use? A Clin-IQ. J Patient Cent Res Rev. 2019;6(4):267–273.
   PubMed Web of Science ®Google Scholar
• Kaufman DE, Nihal AM, Leppo JD, Staples KM, McCall KL, Piper BJ. Opioid mortality following implementation of medical cannabis programs in the United States. Pharmacopsychiatry 2021;54(2):91–95.
   PubMedGoogle Scholar
• Goodman S, Hammond D. International Cannabis Policy Study Technical Report–Wave 1 (2018). Waterloo, ON: University of Waterloo; 2019. Available at: http://cannabisproject.ca/methods/. Accessed April 20, 2021.
   Google Scholar
• Goodman S, Burkhalter R, Hammond D. International Cannabis Policy Study Technical Report–Wave 2 (2018). Waterloo, ON: University of Waterloo; 2020. Available at: http://cannabisproject.ca/methods/. Accessed April 20, 2021.
   Google Scholar
• Hammond D, Goodman S, Wadsworth E, Rynard V, Boudreau C, Hall W. Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study. Int J Drug Policy. 2020;77:102698.
   PubMed Web of Science ®Google Scholar
• Tattan-Birch H, Marsden J, West R, Gage SH. Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID-19. Addiction. 2021;116(5):982–984.
   PubMed Web of Science ®Google Scholar
• Powell D, Pacula RL, Jacobson M. Do medical marijuana laws reduce addictions and deaths related to pain killers? J Health Econ. 2018;58:29–42.
   PubMed Web of Science ®Google Scholar
• Ishida JH, Wong PO, Cohen BE, Vali M, Steigerwald S, Keyhani S. Substitution of marijuana for opioids in a national survey of US adults. PLoS One. 2019;14(10):e02225.
   Web of Science ®Google Scholar